NCT01890941已完成2 期
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 主要终点
- Score of the Corneal conjunctival staining
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Corneal and conjunctival damage
- •Insufficiency of lacrimal secretion
- •Ocular symptom
排除标准
- •Severe ophthalmic disorder
- •Punctual plugs or surgery for occlusion of the lacrimal puncta
研究组 & 干预措施
KCT-0809 Lower Dose
Experimental
干预措施: KCT-0809 ophthalmic solution (Drug)
KCT-0809 Higher Dose
Experimental
干预措施: KCT-0809 ophthalmic solution (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Score of the Corneal conjunctival staining
时间窗: 8weeks
次要结局
- Incidences of Adverse Events(8weeks)
研究者
相似试验
已完成
2 期
A Study of KCT-0809 in Patients With Dry Eye SyndromesDry Eye SyndromesNCT01211951Kissei Pharmaceutical Co., Ltd.160
已完成
2 期
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesDry Eye SyndromesNCT01692145Kissei Pharmaceutical Co., Ltd.
已完成
3 期
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeDry Eye With Sjögren's SyndromeNCT02503189Kissei Pharmaceutical Co., Ltd.
已完成
2 期
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesBipolar DisorderNCT01725308Astellas Pharma Inc431
已完成
2 期
A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)SchizophreniaNCT00827918Merck Sharp & Dohme LLC216